Healthcare fundraising has changed in 2024. The era of mega-rounds handed out left and right is gone, and so is investor fascination with the most innovative players with mind-blowing technology:

  • Funding rounds have shrunk, reflecting the 43% drop in healthtech funding—$10.7B in 2023 compared to $15.3B in 2022
  • A shift in focus: 42% of healthcare deals in 2023 targeted later-stage companies, prioritizing capital efficiency and profitability

However, the future of healthcare isn’t all doom and gloom. Current healthcare venture capital trends signal numerous opportunities for those who can ride the wave:

  • M&A deals rise: 54% of health sector CEOs aim to complete at least one acquisition within the next three years. 
  • Focus on GenAI: Top VC players such as Andreessen Horowitz back startups building AI tools—Genesis Therapeutics has recently secured a $200M funding round.
  • Big tech entry: Tech giants like Google, Amazon, and Apple plan to join the funding party, seeking AI-powered solutions that streamline healthcare processes. For instance, Amazon has already launched HealthScribe, a tool to summarize doctor visits. 

To help you navigate your investor outreach and fundraise successfully in 2024, we’ve handpicked the top active VC players in the healthcare area, along with their investment criteria and contact details.

Waveup offers fundraising support and investor outreach services to startups
Learn more

1. New Enterprise Associates

➡️ NEA has supported healthcare and tech companies globally for over five decades, boasting a portfolio of over 2K investments and a total committed capital of $19B. The fund invests across all stages, primarily zeroing in on seed and Series A+ rounds.  

Location: Menlo Park, California

Industries: Software, Life Sciences, Digital Health, Biotechnology, Information Technology

Funding stage: Seed, Early Stage, Late Stage

Average check size: $5M-$40M

Total funding amount: $25B

Number of investments: 2166

Average number of rounds per year: 46

Number of exits: 589

Notable portfolio companies: Hyperion Therapeutics, MasterClass, Coursera, Patreon

Contacts: Contact page, LinkedIn

2. High-Tech Gründerfonds

➡️ High-Tech Grunderfonds is a seed investor focused on digital health, industrial tech, and chemicals sectors. The fund primarily backs German ventures, requiring a German operational base for startups elsewhere in Europe.

Location: Bonn, Germany

Industries: Software, Biotechnology, Health Care

Funding stage: Seed, Early Stage 

Value-added beyond money

  • HTGF Academy—a platform for portfolio companies (seminars, workshops, and training sessions)

Average check size: $0.5M-$10M

Total funding amount: $1.4B

Number of investments: 869

Average number of rounds per year: 55

Number of exits: 112

Notable portfolio companies: INERATEC, Emergence Therapeutics, Instagrid

Contacts: Contacts, Send-your-pitch, LinkedIn

3. OrbiMed

➡️ OrbiMed, a global healthcare venture capital firm, invests from seed-stage ventures to large publicly traded companies. With over $17B in funds under management and offices in New York, San Francisco, London, Mumbai, Shanghai, Hong Kong, and Herzliya, it supports founders dedicated to meeting untapped medical needs and improving patient health outcomes.

Location: New York, US

Industries: Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics

Funding stage: Early Stage, Late Stage, Post-IPO, Private Equity

Average check size: $20M-$40M

Total funding amount: $8.6B

Number of investments: 651

Average number of rounds per year: 18

Number of exits: 241

Notable portfolio companies: AbCellera, ACELYRIN, Acutus Medical

Contacts: Contact-us page, LinkedIn

4. Atlas Venture

➡️ Atlas Venture is a hub for healthcare venture capital. With 32 mergers and acquisitions exits, 39 IPOs, and over 70 startups launched from its incubator, the firm has championed disruptive biotech and pharma companies for over 30 years. 

Location: Cambridge, US

Industries: Biotechnology, Health Care, Software, Therapeutics

Funding stage: Seed, Early Stage, Late Stage 

Average check size: $20M-$50M

Total funding amount: $3.6B

Number of investments: 595

Average number of rounds per year: 13

Number of exits: 183

Notable portfolio companies: Aiolos Bio, Solyndra, Nimbus Therapeutics

Contacts: LinkedIn

5. Dreamit Ventures

➡️ Dreamit Ventures invests in founders who build transformative healthtech and securetech companies. Beyond the capital, the fund provides access to meeting, piloting, and partnering with the leaders of military, healthcare, and federal agencies.  

Location: New York, US

Industries: Health Care, Software, Information Technology

Funding stage: Seed, Early Stage 

Average check size: $3M-$6M

Total funding amount: $84.8M

Number of investments: 394

Average number of rounds per year: 23

Number of exits: 48

Notable portfolio companies: NeuroFlow, Cherre, RaySecur

Contacts: Contact-us page, LinkedIn

Remember: in 2024, investors seek the most resilient startups with strong business acumen, robust GTM strategy, and potential for quick returns. Show it all in your pitch deck.

Don’t know how to do it right? Check our pitch deck mistakes guide for insights straight from the trenches
Check now!

6. Maverick Ventures

➡️ Maverick Ventures, a venture arm of Maverick Capital, backs early-stage entrepreneurs across tech and healthcare sectors. 

Location: San Francisco, US

Industries: Health Care, Biotechnology, Medical

Funding stage: Seed, Early Stage, Late Stage 

Average check size: $20M-$40M

Total funding amount: $382M

Number of investments: 186

Average number of rounds per year: 18

Number of exits: 36

Notable portfolio companies: Devoted Health, Groupon, Heap

Contacts: LinkedIn

7. Versant Ventures

➡️ Versant Ventures provides early and late-stage healthcare venture capital, private equity, and debt financing investments. With offices in the USA, Europe, and Canada and over $4.2B in funds under management, the firm has already seen over 70 of its companies successfully acquired or gone public through IPOs. 

Location: San Francisco, US

Industries: Health Care, Biotechnology, Medical, Therapeutics

Funding stage: Early Stage Venture, Late Stage Venture, Private Equity

Value-added beyond money

  • Discovery Engines—two hubs with in-house scientists who leverage cutting-edge laboratory resources to transform academic innovations into viable biotech startups.  

Average check size: $30M-$60M

Total funding amount: $3.3B

Number of investments: 372

Average number of rounds per year: 14

Number of exits: 106

Notable portfolio companies: Century Therapeutics, Jazz Pharmaceuticals, Passage Bio

Contacts: Contacts page, LinkedIn

8. Pitango VC

➡️ Pitango VC invests across multiple industries and stages. It partners with stellar teams via three funds: Pitango HealthTech, PitangoGrowth, and Pitango First. 

Location: Herzliya, Israel

Industries: Software, Health Care, Information Technology, Biotechnology

Funding stage: Early Stage Venture, Late Stage Venture, Seed

Value-added beyond money: A value-add platform provides portfolio companies with access to the fund’s knowledge, expertise, and network.

Average check size: $10M-$20M

Total funding amount: $2.1B

Number of investments: 360

Average number of rounds per year: 11

Number of exits: 65

Notable portfolio companies: Lumen, AppsFlyer, Silk

Contacts: Contact-us page, LinkedIn

9. SV Health Investors

➡️ SV Health Investors is one of the world’s most experienced investment managers. This stage and geography-agnostic fund supports biotech and healthcare startups that aim to improve patients’ lives. 

Location: Boston, US

Industries: Health Care, Biotechnology, Medical, Medical Device

Funding stage: Early Stage Venture, Late Stage Venture

Average check size: $20M-$50M

Total funding amount: $2.6B

Number of investments: 308

Average number of rounds per year: 10

Number of exits: 88

Notable portfolio companies: AvidXchange, Nimbus Therapeutics, Amwell

Contacts: Contacts, LinkedIn

Despite the drop in funding, healthcare startups have all the chances to disrupt the market

2024 is a great time to launch if you have:

  • A solution that solves a significant customer problem 
  • A rock-solid business plan;
  • A clear path to profitability;
  • An investor-appealing deck;
  • An effective investor outreach strategy.

If you don’t know where to start, check our financial and pitch deck hubs for tried-and-true tips and insights. Or, cut the corners and contact our team for assistance.

27 posts

Ruslana

CONTENT WRITER

Hello! I'm Ruslana, a Content Writer at Waveup. Based on my background in marketing research and business analytics, and my current collaboration with the savvy team at Waveup, I'm excited to share my insights and learnings with you.